Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Current Cancer Drug Targets|July 22, 2020
Tumor-Induced Metabolism and T Cells Located in Tumor EnvironmentSara Iranparast, Sanaz Tayebi, Fatemeh Ahmadpour, et al.
Cancer Cell International|December 29, 2022
Interactions of melatonin with various signaling pathways: implications for cancer therapyAinaz Mihanfar, Bahman Yousefi, Bita Azizzadeh, et al.
Journal of Physiology and Biochemistry|February 19, 2014
Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: role of mitochondrial ATP-sensitive potassium channelsHadi Ebrahimi, Reza Badalzadeh, Mustafa Mohammadi, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2016
Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or ChallengeBahman Yousefi, Nosratollah Zarghami, Nasser Samadi, et al.
Current Medicinal Chemistry|March 1, 2023
Application of Nanoparticles for Efficient Delivery of Quercetin in Cancer CellsMina Homayoonfal, Azadeh Aminianfar, Zatollah Asemi, et al.
Cancer Cell International|May 1, 2026
Decoding notch signaling pathway: an updated insight into its role in colorectal cancer progression and therapyMehran Molavand, Azita Asadi, Maryam Majidinia, et al.
Cellular & Molecular Biology Letters|January 4, 2022
The role of polyphenols in overcoming cancer drug resistance: a comprehensive reviewParisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Critical Reviews in Food Science and Nutrition|April 27, 2021
Targeting microRNAs by curcumin: implication for cancer therapyFatemeh Sadoughi, Parisa Maleki Dana, Zatollah Asemi, et al.
Journal of Cellular Physiology|April 21, 2019
New potentials for 3-hydroxy-3-methyl-glutaryl-coenzymeA reductase inhibitors: Possible applications in retarding diabetic complicationsSaman Bahrambeigi, Mahdi Rahimi, Bahman Yousefi, et al.
Pageof 32